Partnership Will Support New Age Medical’s National Expansion, Entry into New Specialties, and M&A-Driven Growth
STAMFORD, Conn., Sept. 28, 2026 — Avesi Partners (“Avesi”) announced that it has made an investment in New Age Medical (“New Age” or the “Company”), a leading MedTech hub serving the spinal surgery market. Avesi has partnered alongside New Age’s founder and CEO, Kevin Bly, and the Company’s existing management team to support New Age’s mission of enhancing patient care and driving operational efficiency by optimizing and accelerating the flow of medical solutions from manufacturers, through reps, to hospitals, surgeons, and patients.
Headquartered in St. Louis, MO, New Age Medical sits at the intersection of medical device manufacturers, hospitals & ambulatory surgery centers (“ASCs”), surgeons, and medical device sales representatives. New Age works nationwide with 85+ original equipment manufacturers (“OEMs”), 100+ reps, 200+ hospitals/ASCs, and 350+ surgeons, ensuring leading technology is accessible to those who need it. The New Age model reduces supply chain complexity and enables vendor consolidation for hospitals and ASCs, while bringing surgeons and patients the most innovative products OEMs have to offer.
“When we founded New Age Medical in 2012, the goal was simple: make it easier for surgeons to get the right products for their patients, and easier for the manufacturers building those products to reach them,” said Kevin Bly, Founder and Chief Executive Officer of New Age Medical. “Avesi shares our conviction that durable growth is the result of doing right by every stakeholder we serve—surgeons, hospitals, manufacturers, and the reps who bring it all together. The cultural alignment between our two organizations was clear from our very first conversation, as was a shared, growth-oriented mindset. With Avesi’s commitment and resources behind us, we can extend best-in-class product access to more surgeons, more facilities, more reps and ultimately more patients across the country.”
“Avesi has targeted innovative businesses that help hospitals and health systems deliver the highest standards of care while reducing administrative burden,” said Pete Tedesco, Managing Director at Avesi. “New Age delivers this value to its stakeholders and operates in a large, growing market with substantial opportunity to expand. We look forward to pairing our resources and healthcare expertise with the talented team at New Age to continue delivering exceptional service and extend the Company’s impact across new specialties and markets.”
“New Age Medical is one of a kind in its sector given its long-term track record of growth, the strength of its relationships across surgeons, reps, OEMs, and facilities, and the differentiated value it delivers to each,” said Chris Laitala, Managing Partner at Avesi. “Our team at Avesi is excited to work alongside management in the coming years to further expand the Company’s reach and capabilities.”
About New Age Medical
New Age Medical is the MedTech hub that optimizes and accelerates the flow of medical solutions from manufacturers, through reps, to hospitals and surgeons, all with the overarching goal of enhancing patient care and driving operational efficiency. Founded in 2012 and headquartered in St. Louis, MO, New Age works with 85+ OEMs, 100+ reps, 200+ hospitals/ASCs, and 350+ surgeons nationwide, providing top-quality spinal implants, orthobiologics, and related products to ensure exceptional patient care.
For more information, visit https://newagemedical.com/ or https://www.linkedin.com/company/new-age-medical-llc/.
About Avesi Partners
Avesi Partners, with offices in Stamford, CT and Richmond, VA, and over $2.2 billion in assets under management, focuses on partnering with lower-middle market privately held and family-owned businesses in key sectors of the economy, including healthcare services and technology, and business services. Avesi seeks to provide the expertise and resources to empower businesses to attain their full vision in a time and capital efficient manner. Avesi’s goal is to collaborate with families, founders, and executives to accelerate growth and expansion while positioning the businesses to achieve long-term success and enduring value. Target platform companies typically have approximately $5-30 million of EBITDA.
For further information, visit www.avesipartners.com or www.linkedin.com/company/avesi-partners.
New Age Medical Contact
[email protected]
Avesi Contact
[email protected]
SOURCE Avesi Partners
